Viewing Study NCT02180503


Ignite Creation Date: 2025-12-24 @ 7:35 PM
Ignite Modification Date: 2026-01-05 @ 1:28 AM
Study NCT ID: NCT02180503
Status: COMPLETED
Last Update Posted: 2014-07-08
First Post: 2014-07-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Relative Bioavailability of 1 mg and 10 mg BI 1356 BS as Powder in the Bottle (PIB) to 1 mg and 10 mg BI 1356 BS as Tablets as Single Oral Administration in Healthy Male Volunteers Including the Influence of Food on the Bioavailability of 10 mg BI 1356 BS
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module